DPP4 is a ubiquitously expressed transmembrane protein that reduces the expression level of glucagon-like peptide 1 and regulates NAFLD through autocrine and paracrine effects on hepatic insulin signaling [34]. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatotic liver disease.